Emerging glycobiology tools: A renaissance in accessibility

Por Oswald, Douglas M., Cobb, Brian A.
Publicado no Cell Immunol (2018)

Modulation of hepatocyte sialylation drives spontaneous fatty liver disease and inflammation

Por Oswald, Douglas M, Jones, Mark B, Cobb, Brian A
Publicado no Glycobiology (2019)

Disruption of Hepatocyte Sialylation Drives a T cell-Dependent Pro-Inflammatory Immune Tone

Por Oswald, Douglas M., Zhou, Julie Y., Jones, Mark B., Cobb, Brian A.
Publicado no Glycoconj J (2020)

B-cell–independent sialylation of IgG

Por Jones, Mark B., Oswald, Douglas M., Joshi, Smita, Whiteheart, Sidney W., Orlando, Ron, Cobb, Brian A.
Publicado no Proc Natl Acad Sci U S A (2016)

The Glycoscience of Immunity

Por Zhou, Julie Y., Oswald, Douglas M., Oliva, Kelsey D., Kreisman, Lori S.C., Cobb, Brian A.
Publicado no Trends Immunol (2018)

T cell-intrinsic TLR2 stimulation promotes IL-10 expression and suppressive activity by CD45Rb(Hi) T cells

Por Jun, Janice C., Jones, Mark B., Oswald, Douglas M., Sim, Edward S., Jonnalagadda, Amruth R., Kreisman, Lori S. C., Cobb, Brian A.
Publicado no PLoS One (2017)

Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infections

Por Oswald, Douglas M., Sim, Edward S., Baker, Courtney, Farhan, Obada, Debanne, Sara M., Morris, Nathan J., Rodriguez, Benigno G., Jones, Mark B., Cobb, Brian A.
Publicado no FASEB J (2019)